Lv2
110 积分 2023-05-04 加入
Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007–23)
13小时前
待确认
Interleukin-5 and Interleukin-5 Receptor Polymorphism in Asthma
6个月前
已关闭
Comparison of tucidinostat with CHOP-like versus CHOP-like in first-line treatment of peripheral T-cell lymphoma: a single-center real-world study
10个月前
已完结
Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT
1年前
已完结
Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia
2年前
已完结
Inotuzumab ozogamicin，an anti ‐ CD22 ‐ calecheamicin conjugate，for refractory and relapsed acute lymphocytic leukaemia:a phase 2 study
2年前
已完结
Flow cytometric study of potential target antigens (CD19， CD20， CD22， CD33) for antibody ‐ based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases
2年前
已完结
Participation in breast cancer risk counseling among women with a family history
2年前
已关闭
Participation in breast cancer risk counseling among women with a family history
2年前
已关闭
Updates in the Management of Relapsed and Refractory Acute Lymphoblastic Leukemia: An Urgent Plea for New Treatments Is Being Answered!
2年前
已完结
皖公网安备34019202002308
